RMD - ResMed slips as Wolfe downgrades citing a balanced outlook
2023-09-29 15:25:38 ET
More on ResMed
- Here's The Price I'll Buy ResMed Stock
- ResMed - Trading Opportunity Now
- ResMed: Stock Re-Rating To 20x Forward P/E Is A Buy Opportunity
- ResMed hits 52-week low after Q4 miss
- ResMed upgraded at RBC Capital Markets ahead of Q4 earnings
For further details see:
ResMed slips as Wolfe downgrades citing a balanced outlook